Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 238

1.

Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.

Nichols KE, Ma CS, Cannons JL, Schwartzberg PL, Tangye SG.

Immunol Rev. 2005 Feb;203:180-99. Review.

PMID:
15661030
[PubMed - indexed for MEDLINE]
2.

Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.

Tangye SG, Phillips JH, Lanier LL, Nichols KE.

J Immunol. 2000 Sep 15;165(6):2932-6.

PMID:
10975798
[PubMed - indexed for MEDLINE]
Free Article
3.

Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.

Lewis J, Eiben LJ, Nelson DL, Cohen JI, Nichols KE, Ochs HD, Notarangelo LD, Duckett CS.

Clin Immunol. 2001 Jul;100(1):15-23.

PMID:
11414741
[PubMed - indexed for MEDLINE]
4.

Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation.

Tangye SG, Nichols KE, Hare NJ, van de Weerdt BC.

J Immunol. 2003 Sep 1;171(5):2485-95.

PMID:
12928397
[PubMed - indexed for MEDLINE]
Free Article
5.

NK cell regulation by SLAM family receptors and SAP-related adapters.

Veillette A.

Immunol Rev. 2006 Dec;214:22-34. Review.

PMID:
17100873
[PubMed - indexed for MEDLINE]
6.

Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.

Chen R, Relouzat F, Roncagalli R, Aoukaty A, Tan R, Latour S, Veillette A.

Mol Cell Biol. 2004 Jun;24(12):5144-56.

PMID:
15169881
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Missense mutations in SH2D1A identified in patients with X-linked lymphoproliferative disease differentially affect the expression and function of SAP.

Hare NJ, Ma CS, Alvaro F, Nichols KE, Tangye SG.

Int Immunol. 2006 Jul;18(7):1055-65. Epub 2006 May 23.

PMID:
16720617
[PubMed - indexed for MEDLINE]
Free Article
8.

Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.

Sayós J, Nguyen KB, Wu C, Stepp SE, Howie D, Schatzle JD, Kumar V, Biron CA, Terhorst C.

Int Immunol. 2000 Dec;12(12):1749-57.

PMID:
11099315
[PubMed - indexed for MEDLINE]
Free Article
9.

Molecular and immunological basis of X-linked lymphoproliferative disease.

Latour S, Veillette A.

Immunol Rev. 2003 Apr;192:212-24. Review.

PMID:
12670406
[PubMed - indexed for MEDLINE]
10.

Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family.

Fraser CC, Howie D, Morra M, Qiu Y, Murphy C, Shen Q, Gutierrez-Ramos JC, Coyle A, Kingsbury GA, Terhorst C.

Immunogenetics. 2002 Feb;53(10-11):843-50. Epub 2002 Jan 23.

PMID:
11862385
[PubMed - indexed for MEDLINE]
11.

Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product.

Latour S, Gish G, Helgason CD, Humphries RK, Pawson T, Veillette A.

Nat Immunol. 2001 Aug;2(8):681-90.

PMID:
11477403
[PubMed - indexed for MEDLINE]
12.

The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells.

Nagy N, Mattsson K, Maeda A, Liu A, Székely L, Klein E.

Immunol Lett. 2002 Jun 3;82(1-2):141-7.

PMID:
12008045
[PubMed - indexed for MEDLINE]
13.

Immune regulation by SLAM family receptors and SAP-related adaptors.

Veillette A.

Nat Rev Immunol. 2006 Jan;6(1):56-66. Review.

PMID:
16493427
[PubMed - indexed for MEDLINE]
14.

Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice.

Graham DB, Bell MP, McCausland MM, Huntoon CJ, van Deursen J, Faubion WA, Crotty S, McKean DJ.

J Immunol. 2006 Jan 1;176(1):291-300. Erratum in: J Immunol. 2006 Mar 15;176(6):3841.

PMID:
16365421
[PubMed - indexed for MEDLINE]
Free Article
15.

The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease.

Engel P, Eck MJ, Terhorst C.

Nat Rev Immunol. 2003 Oct;3(10):813-21. Review.

PMID:
14523387
[PubMed - indexed for MEDLINE]
16.

X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.

Parolini S, Bottino C, Falco M, Augugliaro R, Giliani S, Franceschini R, Ochs HD, Wolf H, Bonnefoy JY, Biassoni R, Moretta L, Notarangelo LD, Moretta A.

J Exp Med. 2000 Aug 7;192(3):337-46.

PMID:
10934222
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.

Schuster V, Kreth HW.

Immunol Rev. 2000 Dec;178:21-8. Review.

PMID:
11213803
[PubMed - indexed for MEDLINE]
18.
19.

Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4).

Romero X, Benítez D, March S, Vilella R, Miralpeix M, Engel P.

Tissue Antigens. 2004 Aug;64(2):132-44.

PMID:
15245368
[PubMed - indexed for MEDLINE]
20.

Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244).

Eissmann P, Beauchamp L, Wooters J, Tilton JC, Long EO, Watzl C.

Blood. 2005 Jun 15;105(12):4722-9. Epub 2005 Feb 15.

PMID:
15713798
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk